Vol 25: Impact of tumor HPV status on outcome in patients with recurrent and-or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXReportar como inadecuado



 Vol 25: Impact of tumor HPV status on outcome in patients with recurrent and-or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EX


Vol 25: Impact of tumor HPV status on outcome in patients with recurrent and-or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EX - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Descargar gratis o leer online en formato PDF el libro: Vol 25: Impact of tumor HPV status on outcome in patients with recurrent and-or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EX
This article is from Annals of Oncology, volume 25.AbstractAdding cetuximab to chemotherapy improved survival in patients with recurrent-metastatic squamous cell carcinoma of the head and neck. Although HPV and p16 statuses have prognostic value, the observed survival benefit conferred by cetuximab is independent of both. This pattern remained in a combined analysis of both p16 and HPV and in patients with oropharyngeal cancer separately.



Autor: Vermorken, J. B.; Psyrri, A.; Mesia, R.; Peyrade, F.; Beier, F.; de Blas, B.; Celik, I.; Licitra, L.

Fuente: https://archive.org/







Documentos relacionados